Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer.
Saved in:
| Title: | Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer. |
|---|---|
| Authors: | Feliu, J.1 jfeliu.hulp@salud.madrid.org, Borrega, P.2, León, A.3, López-Gómez, L.4, López, M.5, Castro, J.1, Belda-Iniesta, C.1, Barriuso, J.1, Martínez, V.1, González-Barón, M.1 |
| Source: | Cancer Chemotherapy & Pharmacology. Jan2011, Vol. 67 Issue 1, p215-221. 7p. |
| Database: | Academic Search Ultimate |
| ISSN: | 03445704 |
|---|---|
| DOI: | 10.1007/s00280-010-1472-0 |
